Skip to main content
Signal8

Kiernan Jane E

SEC insider (Form 3/4/5 filer). CIK 0001379171. Director at TREACE MEDICAL CONCEPTS, INC. (TMCI) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in IRVINE, CA.

Companies Kiernan Jane E has filed insider reports for

  • TREACE MEDICAL CONCEPTS, INC. (TMCI): Director
  • Axonics, Inc. (AXNX): Director
Kiernan Jane E profile photo

Kiernan Jane E

CIK: 0001379171

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TREACE MEDICAL CONCEPTS, INC. logo
TMCI

TREACE MEDICAL CONCEPTS, INC.

Director
Axonics, Inc. logo
AXNX

Axonics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • TREACE MEDICAL CONCEPTS, INC. logo
    TMCI

    TREACE MEDICAL CONCEPTS, INC.

    May 19, 2026
    Award
    Direct
    30K shares-
  • TREACE MEDICAL CONCEPTS, INC. logo
    TMCI

    TREACE MEDICAL CONCEPTS, INC.

    May 20, 2025
    Award
    Direct
    23.9K shares-
  • Axonics, Inc. logo
    AXNX

    Axonics, Inc.

    Nov 15, 2024
    Disposition
    Direct
    19.9K shares at avg. $71.00$1.4M

1-3 of 3